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1. Introduction  
1.1 Traumatic Brain Injury 
1.1.1 Definition 
Traumatic brain injury (TBI) is defined as a non-degenerative lesion to the skull and 
intracranial structures (brain parenchyma, meninges, cerebral vessels) caused by direct 
or indirect external force [1].  
 
1.1.2 Epidemiology and Etiology 
TBI is a major public health problem in developed as well as developing country as it is a 
major cause for death and disability, especially in children and younger (<45 years) 
patients. Incidence data varies considerably between countries and studies as there is no 
unambiguous definition of TBI and as mild cases of TBI that are not treated in a hospital 
often go unreported [2, 3]. In 2011, the incidence of TBI in Germany was  to be 
332/100,000; in most cases  90.9%), TBI was considered mild, moderate (3.9%), or 
severe cases (5.2%) were much less frequent [4]. Recently published data [5] (Figure 1) 
record a mean incidence of 287.2 / 100,000 people per year in Europe, with enormous 
differences between countries (from 50 to 650/ 100,000) that are more likely to reflect 
differences in design of the study rather than true variation [3]. In a comprehensive 
review in 2016 that investigated fatal TBI cases and cases requiring hospital treatment in 
all European countries, rough incidence of TBI in Europe ranged from 47.3 per 100,000, 
to 694 per 100,000 population per year in country-wide  and from 83.3 per 100,000, to 
849 per 100,000 population per year in regional-level studies. Mortality resulting from 
traumatic brain injury ranged from 9 to 28.1 per 100,000 population per year 
(country-level), and from 3.3 to 24.4 per 100,000 population per year in regional-level 
studies. In another systematic review published in 2006, incidence rate of TBI in Europe 
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was approximately 235 per 100,000, mortality rate 15 per 100,000 population. This 
study included all TBI cases and found that in hospitalized patients the ration of mild, 
moderate, and severe TBI was approximately 22:1.5:1 [6]. In the United States incidence 
of TBI is estimated around 180-220/100,000, resulting in approximately 600,000 TBI 
cases per year, with 10% of these cases being fatal injuries [7].  
 
Figure 1: Worldwide incidence of traumatic brain injury [5] 
In China (population 1.3 billion), there is no reliable nationwide data on the incidence of 
TBI. Report from the 1980s and one study investigating civilian inpatients 
of Chinese Military Hospitals from 2001-2007 state an incidence of 55.4 – 64.1 per 
100,000 per year; These numbers are much lower than the estimates for other countries 
which probably reflects incomplete case ascertainment [8-11]. The World Health 
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Organization (WHO) estimates that the incidence of (mild) TBI may even be significantly 
higher than previously described in the literature [3, 12], because of different case 
definitions and methods of data collection. Furthermore, as motorization will probably 
increase, especially in developing countries, overall TBI incidence and mortality 
worldwide is predicted to significantly increase in the next decade [13].The most 
common mechanisms of injury of TBI are traffic accidents and falls [3]. The etiology is 
age-dependent: in childhood and in elder patient, TBI is most often caused by falls while 
traffic and motor vehicle accidents account for the majority of TBI in early to 
mid-adulthood [14]. Most of TBI cases were caused by traffic accidents [15, 16], while 
falls account for the major part of the TBIs in Europe, most notably in elderly patients [2, 
3, 15, 17]. Young men (15-24 years) are the high-risk population for TBI [18, 19] due to 
the traffic accidents [15, 16]. Alcohol is associated with the leading causes of TBI [15]. 
Over time, the contribution of traffic accidents to total TBI events is declining in 
industrialized countries due to preventive measures (safety belts, helmets for cyclists [20] 
and motor-bikers) [15]; at the same time the percentage of aging patients in the same 
regions will probably increase the frequency of fall-related TBI. In developing countries, 
however, motorization will sharply increase in the near future, therefore the number of 
traffic accidents, and, thus, traffic-accident-related TBI, may also increase in these 
countries. 
 
1.1.3 Classification of Traumatic Brain Injury  
Traumatic brain injury can be categorized by severity, injury mechanism, and leading 
pathophysiololgy. For clinical practice, the classification of severity based on the Glasgow 
Coma Scale (GCS) is widely used as an assessment tool in emergency care. The GCS, first 
describe by Teasdale and Jeannett in 1974 [21] is a clinical score used to describe the 
general level of consciousness of TBI patients. GCS evaluates of three tasks/ functions: 

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eye opening (E, maximum of 4 points), verbal response (V, max. 5 points), and motor (M, 
maximum of 6 points) (Figure 2), maximum score is 15 points in healthy patients, 
minimum score of 3 points (deep coma) [21]. 
  Eye Verbal Motor 
1 Does not open eyes Makes no sounds Makes no movements 
2 Opens eyes in response 
to painful stimuli 
Incomprehensible sounds 
Extension to painful stimuli 
3 Opens eyes in response 
to voice 
Utters incoherent words Abnormal flexion to painful 
stimuli 
4 Opens eyes 
spontaneously 
Confused, disoriented Flexion / Withdrawal to painful 
stimuli 
5 N/A Oriented, converses 
normally 
Localizes to painful stimuli 
6 N/A N/A Obeys commands 
 
Figure 2: Glasgow Coma Scale [21] 
When initial GCS score after TBI is 13-15 head injury is classified as “mild”; moderate 
head injury is defined by a GCS score of 9-12. When consciousness is severely impaired 
after TBI, i. e. the GCS score is 8 or less, brain injury has to be considered severe [21]. 
GCS is not valid in intubated patients, intubation and sedation also may alter motor and 
eye response. Also, GCS is used when the doctor first sees the patient after the injury, 
before intubation. This classification allows for a rough estimate of  prognosis and 
outcome after TBI: In mild traumatic brain injury there is no or only a short-lasting of 
disturbance of consciousness (<30 minutes), and usually there is no structural damage 
visible in imaging; even though the majority of patients are asymptomatic or suffer only 
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from transient headache and amnesia, they may experience persistent headaches as 
well as long-lasting neurocognitive disorders [22-24]. Moderate brain injury is defined as 
a brain injury resulting in a loss of consciousness from 20 minutes to 6 hours [25] and 
severe brain injury is defined as a brain injury resulting in a loss of consciousness of 
greater than 6 hours [25]. Imaging usually demonstrates structural brain damage such as 
contusions, hemorrhage (epidural, subdural, subarachnoidal, and intraparenchymatous), 
edema, or ischemia [26, 27]. These may be accompanied by epilepsy, hydrocephalus and 
pituitary dysfunction [28-30]. The mortality rate for TBI patients with an initial 
posttraumatic GCS of 3 was 78.4%; initial GCS of 4, 55.9%; and initial GCS of 5, 40.2% 
[31]. If GCS is higher than 8 points, the mortality is only 15%, and approximately 80% of 
patients have a good neurological outcome [32]. However, while GCS scoring is routinely 
and widely used after TBI, the definitions mild/moderate/severe are not consistently 
applied in everyday clinical practice, therefore this categorization is of limited use [27, 
33]. Another way to classify TBI is based on the mechanism of head injury. TBI can be 
described as direct or indirect, dull or penetrating, acceleration or deceleration injury [27, 
34]. Direct dull, and indirect acceleration / deceleration head injury are more likely to 
result in diffuse tissue injury, e. g. the so-called diffuse axonal injury (DAI) [35, 36], direct 
penetrating injury to vascular injuries [34]. The literature also describes the so called 
infringement mechanism after missile and blast injuries which is mainly important in the 
military field [35, 37]; brain damage is the result of several factors: the explosion 
resulting in overpressure which leads to the formation of brain edema, fragments 
causing penetrating injuries to skull and the brain tissue, and heat development resulting 
in burns [38]. There are also image-based or morphological classifications of TBI such as 
the Marshall score which was first described in 1992 and later modified, it remains one 
of most commonly used systems for grading acute TBI on the basis of computed 
tomography (CT) findings [39]. It classifies TBI according to lesions found in computed 
tomography scans [40, 41] and mainly focusses on two features: the degree of brain 
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edema / swelling, as determined by midline shift and / or compression of basal cisterns, 
and the presence and size of contusions / hemorrhages referred to "high or mixed 
density lesions" [40]. The Marshall Score distinguished six categories, diffuse injury I  (no 
visible intracranial pathology), diffuse injury II (midline shift of 0 to 5 mm, basal cisterns 
remain visible, no high or mixed density lesions >25 cm3),  diffuse injury III (swelling, 
midline shift of 0 to 5 mm, basal cisterns compressed or completely effaced, no high or 
mixed density lesions >25 cm3), diffuse injury IV (shift, midline shift > 5mm, no high or 
mixed density lesions >25 cm3), evacuated mass lesion V (any lesion evacuated 
surgically), and non-evacuated mass lesion VI (high or mixed density lesions >25 cm3, not 
surgically evacuated) [40]. Marshall CT classification was related with the mortality and 
the frequency of elevated intracranial pressure (ICP) [39]. Rotterdam scoring system was 
developed recently [41], which specifically described the status of the basilar cisterns 
and the degree of midline shift, along with presence of intraventricular hemorrhage and 
subarachnoid hemorrhage [42-45]. This scoring system was used to compare types of 
mass lesions, recognize the more favorable prognosis associated with epidural 
hematomas [43, 46, 47]. The study of Liesemer et al showed that the survival of children 
with TBI was better than adults in Rotterdam CT score categories representing less 
severe injuries, but higher score categories meant worse survival in children [48]. 
 
1.1.4 Pathophysiology of Traumatic Brain Injury  
1.1.4.1 Primary Brain Damage  
1.1.4.1.1 Contusions 
The primary brain damage occurs at the moment of direct, external violence on skull and 
brain tissue [49], its extents depends on the physical characteristics of the impact. It may 
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be focal (e.g. skull fractures, intracranial hematomas, lacerations, contusions, 
penetrating wounds) or diffuse (as in DAI [50]). The most common direct injuries are 
frontal/temporal contusions, epidural/subdural hematomas, traumatic subarachnoid 
hemorrhages, intracerebral / intraventricular hemorrhage[49, 51, 52]. The most 
common indirect injury observed is DAI [49, 51, 53].  
Brain contusion is a bruising of brain tissue caused by TBI (Figure 3) [54] and formed in 
two ways: direct trauma and acceleration / deceleration injury. The incidence of 
contusion in severe TBI was around 20-30% [55]. This type of injury may lead to a decline 
in psychological function in the long term and may lead to cerebral herniation in an 
emergency situation, which is a life-threatening condition associated with brain edema 
[55]. Therefore, the purpose of the treatment is to prevent the ICP hypertention, and 
surgical resection was operated on that time. Except this typical contusion, multifocal 
hemorrhagic contusion is the other kind of contusion which is associated with broken 
capillaries occurring in grey matter under the cortex [56]. Most cases are caused by 
shearing injuries at the impact time and the outcome is poor if the patient is coma, or 
not [56]. 
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Figure 3: Comparison of a CT scan with a xenon blood-flow radionuclide scan. A. CT scan 
shows bifrontal contusions following severe head trauma (arrows). B. Companion CT 
scan showing xenon uptake demonstrates dark regions (arrows), indicating decreased 
perfusion in the contused brain [57]. 
 
1.1.4.1.2 Hemorrhage 
Cerebral hemorrhage is a common TBI complication [58]. Its incidence is approximately 
13 to 35 % in TBI patients [46, 59] and the increase of hemorrhagical volume happens in 
around 38 to 59 % [60-62]. Cerebral hemorrhage is divided into various types, such as 
delayed traumatic intracerebral hematoma [63], progressive hemorrhage [64, 65], 
traumatic intracerebral hemorrhage [66], and so on. Most of delayed traumatic 
intracerebral hematoma is related to traumatic intracranial aneurysm [67, 68]. Epidural 
hematoma, subdural hematoma, intraparenchymal contusion or hematoma, or 
subarachnoid hemorrhage result in the hemorrhagic progression [64]. One model of 
focal cortical contusion showd that progressive secondary hemorrhage was caused by 
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contusion injury [69]. Coronal brain sections in this study showed that the hemorrhagic 
lesions were between the cortex and the corpus callosum in the ipsilateral hemisphere 
on the early stage after TBI [69], however, hemorrhagic lesions on the surface views of 
the brain expanded to all directions, especially medially and laterally and even depper 
from 3h to 8 h after TBI (Figure 4) [69]. It was the same results as that in a controlled 
cortical impact model [70]. 
 
 
 
Figure 4: Contusion injury results in progressive hemorrhage of a brain contusion in a rat 
impact model. (A–C) Surface views (above), and coronal views of the same brains 
(below), from rats euthanized immediately after, 3 h after, or 8 h after contusion injury, 
as indicated [69]. 
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1.1.4.1.3 Diffuse Axonal Injury 
Diffuse axonal injury (DAI) was found in almost every severe TBI patient [71]. 56% were 
found with DAI in moderate TBI patients [50]. In DAI, stretching injury of brain 
parenchyma leads to an interruption of axonal transport, especially in the corpus 
callosum and in fiber tracts connecting the cerebellum and cerebellum [36, 53, 72, 73]. 
Ultimately, these processes can lead to the death of the axons. Histopathologic findings 
in patients with diffuse axonal injury can be graded as follows : Grade 1 - Axonal injury 
present mainly in parasagittal white matter of the cerebral hemispheres, Grade 2 - 
Grade 1 plus lesions in the corpus callosum, Grade 3 - Grade 2 plus focal lesions in the 
cerebral peduncle [53]. 
 
1.1.4.2 Acute Secondary Brain Injury 
Secondary brain injury is tissue damage that results from a series of pathophysiologic 
changes that are triggered by the original trauma and the primary damage [74]. In 
contrast to the primary lesion whose extent is dependent on the force of the impact only 
and that can only be prevented, not treated, acute secondary brain damage develops in 
a delayed fashion over a period of several days. It is therefore amenable for treatment 
intervention several factors/ mechanisms that contribute to secondary brain damage 
will be explained in detail in the following paragraphs.  
 
1.1.4.2.1 Biochemical Factors involved in Acute Secondary Brain Damage 
Tissue injury sustained in the context of TBI leads to a variety of secondary cellular 
mechanisms that in turn trigger neuroinflammation and eventually lead to cell death.   
Among other things brain injury leads to an increase of excitatory amino acids (EAAs) 
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[75], such as gluatamate toxicity [75], endogenous opioid peptides (e. g. dynorphin-like 
immunoreactive material) [76, 77], extracellular potassium [78], cytokines [79-81], and 
intracellular magnesium [82-84]. Other factors that cause the development of cytotoxic 
brain edema are lactic acidosis due to anaerobic metabolic processes [85-87] and the 
calcium influx caused by oxygen radicals and oxidative stress which was produced by 
EAAs [88]. Otherwise, a rise in extracellular potassium leads to the formation of 
pro-inflammatory cytokines and further neuroinflammation [78]. In addition to the 
above factors, there are a variety of other pathomechanisms that contribute to the 
development of secondary brain damage after TBI. Thus, it could be shown that the 
kallikrein-kinin-system is activated after TBI and it increases the permeability of 
neurovascular and the formation of oxygen radicals which results in the  post-traumatic 
brain edema [88-93].  Another factor that influences secondary necrosis growth is 
disturbed water homeostasis via aquaporins. Several studies show that increased 
expression of aquaporin-4 (AQP-4) occurs after TBI and AQP-4 plays a causative role in 
the development of brain edema via increasing the swelling of astrocytes [94-96]. 
Furthermore, impairment of mitochondrial function also plays a role in the development 
of secondary brain damage [88, 97]. Thus, it has been shown that apoptosis-inducing 
factor (AIF), a mitochondrial, pro-apoptotic molecule, enters the nucleus and leads to 
caspase-independent apoptosis induction [97]. Inhibition of AIF leads to a reduction of 
cell death [97]. Finally, there is an increased release of nitric oxide (NO) immediately 
after TBI [98-103]. However, this increase is only very brief, followed by a prolonged 
inhibition of endothelial nitric oxide synthase (eNOS) and neuronal nitric oxide synthase 
(nNOS) as well as an increase in inducible nitric oxide synthase (iNOS) [98-101, 104]. The 
overall result is an NO deficiency, which can be therapeutically influenced by inhalative 
application of NO, selectively dilates arterioles in the traumatic penumbra, and 
significantly reduces the secondary damage [105, 106]. Furthermore, the increase of 
iNOS seems to induce the formation of secondary damage, however, the inhibition of 
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iNOS reduces secondary necrosis growth [107]. Possible mechanisms of this NO-related 
damage include an induction of oxidative stress via the formation of peroxynitrite, a 
failure of energy production by inhibition of glycolytic or mitochondrial enzymes, and 
DNA damage or inhibition of DNA replication [108]. The other very important 
pathophysiological aspect of the secondary brain damage is triggered by inflammatory 
processes after TBI. It first comes minutes after TBI by exposing negatively charged 
surfaces, such as e.g. basal membranes and release of intracellular molecules, such as 
DNA, RNA and ATP, to activate the contact system [89]. This consists of the coagulation 
factors XI and XII, pre-kallikrein and the non-enzymatic cofactor kininogen, and leads the 
release of bradykinin enzymes from kininogen after activation [109]. In turn, bradykinin 
causes the increased release of NO, leads to vasodilation, the increase of vascular 
permeability and thus causes the formation of brain edema finally [90, 91, 93, 110]. 
Otherwise, vasopressin receptors play a role in the brain edema formation and the 
subsequent development of secondary brain damage after TBI [111] and the inhibition 
of vasopressin receptors could reduce brain edema formation after TBI. The immigration 
of leukocytes comes from hours to days after TBI, although it is still not clear whether 
these have direct influence on the development of secondary brain damage or not. For 
example, the adhesion molecule intracellular adhesion molecule-1 (ICAM-1) was 
knocked out in mice, and a marked reduction of brain edema in the experimental 
traumatic brain injury can be detected while the accumulation of leukocyte was not 
affected, which was a minor role of leukocyte immigration in the acute phase of 
secondary brain damage [112, 113]. While the role of cellular immune response in the 
acute phase of secondary brain damage was minor importance, and it seems that it 
could be even more important in the chronic phase of brain damage. So the activation of 
microglia and immigration of monocytes could take days to months and even up to 
18-years after TBI [114, 115]. Overall, the acute secondary brain damage after TBI is 
mainly influenced by the activation of the contact system, while the cellular Immune 
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response mainly seems to be involved in the development of chronic pathologies of 
brain damage [89, 113, 116, 117]. 
 
1.1.4.2.2 Cerebral Edema and Increased Intracranial Pressure 
Cerebral edema is a determining factor in the development of secondary brain injury. 
Historically, two types of edema are distinguished: vasogenic and cytotoxic edema [88, 
118, 119]. Both types of edema develop at different time points after trauma, they also 
may occur simultaneously [120]. Vasogenic edema is most prominent in the first few 
hours after TBI: early after trauma there is an acute vasodilation that leads to pooling of 
blood within the skull (“vascular engorgement”) [121], there is progressive vessel wall in 
the cerebral microcirculation facilitating leakage of fluid into the interstitial space later 
and vasogenic edema primarily affects the white matter [122]. Cytotoxic cerebral edema 
is due to cellular swelling [123, 124]. It is thought to be the determining factor for 
traumatic brain damage [124-126], and it starts to develop within minutes and may 
persist for up to two weeks [127]. As described above, cell swelling may be due to 
inflammatory processes, release of toxic factors, and oxidative damage. The damage of 
the blood brain barrier (BBB) was also caused by activation of the Kinin-Kallikrein-System, 
vasopressin or Metallo-Matrix-Proteins (MMP) may facilitate cytotoxic edema because 
of BBB leakage [128, 129]. Cytotoxic edema affects predominantly the gray matter [122]. 
Subsequently to the development of posttraumatic brain edema, the intracranial volume 
gradually increases, and the severity of brain edema formation is dependent on the 
severity of trauma. As the brain is housed within a rigid container (skull), it can only 
tolerate small increases in volume within the intracranial compartment before 
intracranial pressure rises dramatically (Monro-Kellie doctrine [130, 131]). The 
intracranial volume (V i/c) consists of the following components: 
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V i/c = V (brain) + V (cerebrospinal fluid) + V (blood) 
 
In the adult, the intracranial volume is about 1500 mL, the brain accounting for 85-90%, 
intravascular cerebral blood volume accounting for 10%, and cerebrospinal fluid (CSF) 
accounting for the remainder (< 3 %). When compensation strategies (expulsion of 
venous blood and CSF) exhausted ICP will increase in an almost linear fashion. This 
intracranial hypertension may lead to herniation [132] which may be life threatening if 
ICP increases massively in a short time [49, 133]. But also a gradual or moderate increase 
in ICP may have disastrous consequences as it may affect cerebral perfusion. Cerebral 
blood flow (CBF) is dependent on the cerebral perfusion pressure (CPP) which is defined 
as the difference between the mean arterial pressure (MAP) and intracranial pressure. 
 
CPP = MAP – ICP 
 
Relationship between cerebral perfusion pressure, mean arterial pressure and 
intracranial pressure [133]. 
If the ICP increased due to the cytotoxic edema, it critically restricted cerebral circulation 
especially the area around the primary damage continues. The penumbra concept 
describes tissue areas located around the primary lesion that do not like the primary 
lesion is irreversibly damaged but reversibly, and offered promise to rescue the brain 
tissue with the appropriate therapies [134], and it is more vulnerable to ischemic brain 
tissue than the intact brain tissue [135, 136]. Due to the blood circulation around 50% of 
the normal value which means the lack of oxygen and the tissue hypoxia, it causes 
mainly anaerobic metabolic processes, in turn, such as anaerobic glycolysis in the 
penumbra [137, 138]. The energy demand increases due to the immigration and 
activation of inflammatory cells [139]. An improvement in ischemia tissue can prevent 
irreversible injury and thus reduce the secondary brain damage [140]. However, it will be 
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irreversible necrosis in the primary injury and traumatic penumbra when the decrease of 
the cerebral blood circulation below the critical threshold 10 ml / 100 g*min-1 [141-143]. 
Depending on the cell death, it comes to leakage of the BBB and subsequently to the 
influx of molecules activated into the interstitial, e.g. intracellular proteins, and it is 
called vasogenic edema [88, 144, 145]. Ultimately, the temporal sequence of the 
post-traumatic brain edema underlying pathophysiological processes is not fully 
informed and remains the basis of controversial discussions [120, 146, 147]. 
 
1.1.4.2.3 Hydrocephalus 
The syndrome of hydrocephalus following head injury was first recognized by Dandy and 
Blackfan in 1914 [148]. HC is common after TBI as high as 51% [149-152], it can present 
either as obstructive and non-obstructive hydrocephalus [153]. The non-obstructive type 
usually caused by the blood or blood degradation products impeding the flow of the CSF 
in the subarachnoid space and the absorption of CSF through the arachnoid villi is more 
frequent after TBI [154]. In obstructive hydrocephalus there is a mechanical blocking of 
CSF passage-ways, mainly by blood clots [153]. The characteristic symptoms of 
hydrocephalus consist of dementia, motor dysfunction, urinary incontinence, cognitive 
dysfunction, and so on [155, 156]. Hydrocephalus results in increased ICP, with 
transependymal exudation of CSF through the ependyma into the brain tissue [157]. Due 
to the ICP increased, cerebral herniation maybe occur in the acute phase, and this may 
manifest itself on CT or Magnetic Resonance Imaging (MRI) as ventricle increased [157]. 
Interstitial edema can be relieved by ventricular drainage [157]. 
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1.1.4.2.4 Clinical Management 
So far, therapy of traumatic brain injury is mainly symptomatic. In the early stages of TBI, 
the aim of clinical management is stabilization of the patients [158]; this includes general 
measures such as management of systemic blood pressure and oxygenation in order to 
ascertain adequate perfusion pressure to the brain. Life threatening conditions such as 
acute hydrocephalus and space occupying lesions such as epidural or subdural 
hematomas should be surgically treated in order to prevent herniation. In the further 
course the main goal of TBI therapy is to lower ICP, increase CBF, and to prevent/ 
alleviate cerebral edema formation. The guidelines of the Brain Trauma Foundation [159] 
recommends a graded approach that includes medical and surgical management 
strategies. A most effective tool to control intracranial hypertension is decompressive 
craniectomy (DC) (Figure 5) [160, 161], and it includes unilateral frontotemporoparietal 
craniotomy and bifrontal craniectomy in usual. While the ICP-lowering effect of this 
intervention is well documented the results regarding the long term neurological 
outcome vary: the DECRA study [162], the first large prospective, randomized, controlled, 
multicenter study evaluating the effect of DC, showed not an unequivocal positive effect 
on mortality and functional [162]; in a recent trial, the ‘RESCUEicp’ study, DC in patients 
with traumatic brain injury and refractory intracranial hypertension led to lower 
mortality, but also higher rates of adverse outcome [163]. In the later stages of TBI 
therapy, patients receive neurorehabilitation, treatment regimens include physical 
therapy, occupational therapy, speech therapy, psychological counseling, vocational 
counseling, and cognitive therapy [164]. Until now, there is no causal treatment strategy 
for posttraumatic brain damage resulting in neuroprotection. Despite many promising 
experimental studies, so far no therapeutical approach proved to confer clinical benefit 
in a clinical trial [52, 165, 166].  
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Figure 5: Decompressive craniectomy [160], A. Unilateral frontotemporoparietal 
craniotomy, a, midline; b, incision in skin.; B. Bifrontal craniectomy, a, midline; b, incision 
in skin. 
 
1.1.4.3 Chronic Secondary Brain Damage 
During the last decades, clinical and pre-clinical research efforts focused on the acute, 
life-threatening pathophysiological events after TBI, i. e. primary and acute secondary 
brain damage. Based on knowledge of the mechanisms of acute brain injury, treatment 
strategies in order to reduce acute posttraumatic brain damage were developed and 
tested with the intent of saving the patients' live and improving neurological outcomes. 
In recent times, however, it is increasingly recognized that the development of 
posttraumatic brain damage after a single TBI can continue for years and may lead to 
progressive deterioration over time [167, 168].  Also, TBI also is believed to be a risk 
factor for developing neurodegenerative disorders such as parkinsonism, cognitive 
decline and dementia [169]. Previous researches showed that occurrence of later-life 
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dementia is more likely when there is a history of a single TBI with loss of consciousness 
[170, 171]; furthermore it is reported that tau and amyloid pathology can be found in TBI 
survivors’ brains decades after the initial injury [172, 173]. Another feature of chronic 
traumatic brain injury is called chronic traumatic encephalopathy (CTE), and its incidence 
was as high as 99% in National Football League (NFL) players in one study [174]. CTE is a 
progressive degenerative disease of the brain found in individuals with a history of 
repetitive brain trauma, symptomatic concussions as well as asymptomatic sub 
concussive hits to the head that do not cause symptoms. It was first described by 
Martland, H.S. in 1928 in pugilists as ‘punch-drunk’ syndrome [175], and in later studies 
observed mainly in athletes that regularly exposed to repetitive brain trauma, e.g. 
boxers, American football players, and ice hockey players. It remains unclear how high 
the risk of developing CTE is for professional sports players [176]; a recent autopsy study 
in professional American Football players reported evidence of CTE in up to 99% of 
individuals albeit in a highly selected group of subjects [174]. This sparked a 
controversial debate about sports associated health risks and medical standards after 
sport-related TBI, but the limitation of this study a highly selected group of individuals. 
TBI-associated dementia might be clinically different from Alzheimer’s disease (AD) [177]. 
Although CTE is similar with AD, there are still significant differences. In general, the 
symptoms of CTE occur earlier than that of AD, which CTE generally present in one’s 40s, 
otherwise symptoms in most AD cases generally present in one’s 60s [178].  Except the 
time of symptoms coming, while the first and most central symptoms of CTE show 
problems with judgment, problem solving, and aggression in usual [177, 179, 180], while 
the first and most central symptoms in AD involve memory problems [178]. In addition, 
these diseases are found to be different in postmortem neuropathological findings.  
On a histopathological level, CTE is characterized by accumulation of phosphorylated tau 
in sulci and perivascular areas of the cerebral cortex in 27 % CTE patients [181], and 95% 
of CTE cases showed widespread diffuse Aβ deposits [182, 183]. A recent study showed 
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that highest levels of abnormal tau protein appear in the CTE brain than that in AD brain 
(Figure 6) [184]. Except for the CTE patients with Tau-associated or Aβ-linked 
post-traumatic Alzheimer's disease (ptAD), little is known about the mechanisms of 
chronic posttraumatic brain damage [185-187]. The few available human post-mortem 
studies show that chronic traumatic brain damage is characterized by brain atrophy [188, 
189] and may be associated with long-lasting neuroinflammation (activated microglia) 
evidenced for up to 18 years after TBI [114, 115]. These findings are corroborated by 
experimental studies in mice and rats showing long-term progressive brain atrophy after 
TBI [190, 191] as well as a long-lasting activation of microglia and monocyte invasion for 
up to 1.5 years after experimental TBI [192]. Whether this is the pathophysiological 
correlate of progressive neurocognitive decline and the cause of progressive 
neurodegeneration is still unclear. As there is uncertainty as to what exactly causes 
chronic posttraumatic brain damage there is no specific or targeted therapeutical 
strategy to alleviate or prevent it.  
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Figure 6: Left to right, brain PET scans of healthy control; former NFL player with 
suspected CTE; and person with AD. Areas with highest levels of abnormal tau protein 
appear red/yellow; medium, green; and lowest, blue [184].  
 
1.2 Aim of the study 
TBI causes long lasting deficits (like dementia, memory loss, depression) in patients that 
often aggravate over time. In order to further understand and – possibly even treat – 
chronic brain damage the time-course and the mechanisms of this phenomenon need to 
be clarified. So far, little is known about the mechanisms of chronic brain damage and 
how they are related and connected to the pathophysiology of acute (secondary) brain 
damage as most of our knowledge about post-traumatic brain damage is derived from 
short-term animal experiments or small human case series. The aim of the present study 
therefore was to characterize the development of chronic neuropathological and 
neurobehavioral changes in a widely used mouse model of experimental traumatic brain 
injury (the so-called controlled cortical impact model) over a period of 12 months. 
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2. Materials and Methods  
2.1 Experimental Animals and Husbandry 
Experiments were carried out on 6-8 -week-old male C57Bl/ 6 mice with a bodyweight of 
20 – 22 g, which were obtained from Charles River Laboratories (Kisslegg, Germany). 
Mice had free access to water and food. The experimental animals were under a 12 
hour-day/ night cycle. Prior to surgery, the mice were housed in groups of up to four 
mice per cage (207 x 140 x 265 mm, Macrolon II, Ehret Life Science Solutions, 
Emmendingen, Germany), after surgery animals were kept individually for one week and 
then put back together. Health screens and hygiene management checks were 
performed in accordance with FELASA guidelines and recommendations. All surgical 
procedures were carried out in accordance with the guidelines of the animal care 
institutions of the Munich University and approved by the appropriate authority, the 
Government of Upper Bavaria (protocol number 55.2-1-54-44-2017). 
 
2.2 Randomization and Blinding  
The experimental animals were randomly assigned to the experiment, allocation to 
different groups and time-points was achieved by drawing lots. The following groups/ 
time-points were examined: naïve animals (non-traumatized), sham surgery, 
post-traumatic groups evaluated at 15 minutes, 1, 7, 30, 90, 180, and 360 days after CCI. 
Figure 7 shows a graphical summary of the experimental groups. Surgical preparation 
and all postoperative behavioral tests were performed in a blinded fashion by a 
researcher unaware of group allocation and postoperative status of the animals.  
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Figure 7: Schematic Overview of Experimental Groups 
 
2.3 Anesthesia and Analgesia 
30 minutes prior to surgery mice received an intraperitoneal injection of buprenorphine 
(Temgesic®, Reckitt Benckiser, Berkshire, UK, 0.1 mg/ kg bodyweight). Anesthesia was 
then induced in a specially prepared anesthesia chamber with 5% isoflurane (1ml / ml, 
250 ml, CP-Pharma®, Burgdorf, Germany) over 45 seconds and then was continued at 
1.5-2% isoflurane in an air/oxygen mixture (69% / 30%) applied by a respiratory mask. In 
order to avoid exsiccation of the cornea eyes were kept closed and protected with 
dexpanthenol cream (Bepanthen®, Bayer, Leverkusen, Germany). After completion of 
surgery animals received 100 % FiO2 until mice fully regained consciousness. For the first 
three days, buprenorphine was injected every 8 hours as painkiller. 
 
2.4 Experimental Traumatic Brain Injury – the Controlled Cortical Impact (CCI) Model 
Traumatic brain injury was induced using the controlled cortical impact model. It was 
first described by James W. Lighthall in ferret in 1988 [193] and later adapted to other 
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species [194]. It has been established in our group approximately 15 years ago and has 
high reproducibility [105, 110, 194-197]. For surgery, animals were positioned in prone 
position with their head fixed in a stereotactic frame (Model 900 Small Animal 
Stereotaxic Instrument, David KOPF Instruments®, Tujunga, California, USA). After 
longitudinal skin incision along the sagittal suture (approximately 2 centimeters long) the 
galea aponeurotica is removed. Under the microscope (Leica M80, Leica, Germany) a 
right parietal craniotomy is performed using a diamond-tipped high speed drill 
(Rewatronik® Products, Wald-Michelbach GmbH, Germany; drill head GD890R, diameter 
0.6 mm, Aesculap, Tuttlingen, Germany); the bone is not dissected at the sagittal suture. 
Location of the craniotomy, which is approximately 5 x 5 mm in size, is depicted in Figure 
8A. The bone flap is then opened towards the sagittal suture exposing the intact dura 
mater (Figure 8B). The animal is placed under the impactor tip of the CCI device 
(Mouse-Katjuscha 2000, L. Kopacz, University of Mainz, Germany, Figure 8C), the tip is 
lowered to the dura under the microscope in order to allow exact perpendicular 
placement of the impactor bolt on the dura in the middle of craniotomy. Trauma 
induction is then carried out with a penetration depth of 1 mm, a dwelling time of the 
punch and an impact velocity of 8 m/s. 
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Figure 8: A: Position of cranial window and trauma. Red rectangle: craniotomy; Blue 
round shape: position of the trauma induction; B: Position of Bone Flap; C: CCI device 
 
The cranial window was immediately closed by replacing the bone flap and fixing it using 
tissue glue (No.1469SB, 3M VetbondTM, USA). The skin wound was sutured by 
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monofilament sutures (6/0, SERAFIT®, SERAG-WIESSNER GmbH, Naila, Germany). Mice 
were then allowed to wake up, until recovery of spontaneous motor activity they 
received 100% O2 via face mask. In order to avoid postoperative hypothermia, they were 
then placed in an incubator (MediHEAT TM, Peco Services, United Kingdom) heated to 32 ° 
C for 60 minutes. Sham operated animals underwent craniotomy and bold placement; 
however, the impact was not triggered. 
 
2.5 Body Weight 
Body weight as a parameter for general wellbeing of experimental animals was 
measured directly before the induction of anesthesia. After CCI it was determined daily 
for the first 7 days; afterwards, animals were weighed once a month until the end of the 
observation period using a precision balance (OHAUS®, Waagendienst Winkler GmbH, 
Munich, Germany).  
 
2.6 Behavioral Testing 
2.6.1 Evaluation of Motor Function - Beam Walk Assessment  
As the posttraumatic brain damage in our model is located in the region of the murine 
motor cortex (hindpaw region) animals show distinct motor deficits after CCI. We 
therefore chose a paradigm that reliably detects motor and gait deficits, the beam walk 
test, which has been previously established in the CCI mouse model [194]. For the test, 
mice were placed on a wooden beam (1 cm width, 100 cm length, 100 cm above ground, 
see Figure 9 for pictures of the set-up). When crossing the beam, the time needed to 
completely traverse the beam is assessed; furthermore the number of missteps with the 
hindpaw contralateral to CCI is counted. Starting 3 days before trauma the beam walk 
test was performed at 1 day, day 3, and day 7 after trauma; afterwards, it was 
conducted every month until the end of the observation period.   
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Figure 9: Experimental Set-up for Beam Walk testing 
 
2.6.2 Depression-like Behavior - Tail Suspension Test 
Tail suspension is a test to evaluate depressive behavior in rodents [198]. For the test, 
the animal is suspended at the tail for three minutes. During this time, the animal is 
continuously video-monitored with a high resolution camera (EthoVision®XT, Noldus 
Information Technology, Netherlands) in order to assess mobility and immobility time, i. 
e. the time the mouse moves in order to recover balance/ the time the mouse does not 
move. For the test, a custom-made device (Figure 10) allowed for testing three animals 
at one time. In order to avoid climbing, a plexiglass cylinder (4 cm length, 1.6 cm outside 
diameter, 1.2 cm inside diameter, 1.6 grams) was placed on the tail (Figure 10). The tail 
suspension test was performed 90, 180, 270, and 360 days after CCI.  
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                Figure 10: The Device for Tail Suspension 
 
2.6.3 Spatial Orientation and Learning Behavior – the Barnes Maze Test 
The Barnes maze is a test paradigm to study spatial learning and memory in rodents [199] 
based on the rodent’s instinctive avoidance of open fields and their natural preference 
for dark and sheltered spaces. The test is performed on a round platform (diameter 100 
cm) that is brightly lit and contains 20 identical holes (diameter 10 cm) spaced evenly 
around the perimeter (Figure 11A). Below one of these apertures there is a so called 
“home-box” (20 X 5 X 3 cm) that provides a sheltered space to escape the brightly lit 
open space of the platform. The aim of the test was for the mouse to correctly identify 
the home-box and arrive there as quickly as possible within the test duration of 180 
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seconds. The whole set-up was monitored with a high resolution camera, the animal´s 
performance digitally recorded; a software then allows to assess the time the mouse 
needs to arrive at the home-box (latency) as well as track the speed and the distance 
travelled (EthoVision®XT, Noldus Information Technology, Netherlands, see Figure 11B 
for photograph of the setup). Three marks are attached in different positions in order to 
guide the mouse towards the location of the home-box. Animals are trained in this test 
paradigm twice daily (with an interval of 4-5 hours) for 4 days, starting 5 days before the 
actual experiment begins. During training phase, in the mornings the mouse is placed 
under a glass cylinder (12 cm diameter, 22 cm height) in the center of the table for 120 
seconds. After that, the mouse is slowly moved with the cylinder towards the home-box 
until the mouse can enter it; the animal is then left in the home-box for 60 seconds. In 
the afternoon, it started when the glass cylinder was moved out of the mouse, so the 
mouse could begin to search the home-box during 180 seconds. For the probe day, we 
did the procedure as the afternoon part and just recorded the latency, distance and 
velocity during 180 seconds. After surgery, test is performed at day 90, 180, 270, and 
360 after the start of the experiment. Repetitive training trails of Barnes Maze were 
performed on Day 85-88, Day 175-178, Day 265-268, and Day 355-358.  
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Figure 11: The Device for Barnes Maze 
 
2.7 Histopathological Assessment of Posttraumatic Brain Damage Parameters 
2.7.1 Tissue Harvesting 
For histological evaluation, coronary floating sections of the brains were prepared as 
previously described [200]. At the end of the respective observation period, animals 
were sacrificed by transcardial perfusion after induction of deep anesthesia achieved by 
intraperitoneal injection of medetomdine (0.5 mg/ kg body weight; Domitor®, Pfizer, 
Karlsruhe, Germany), midazolam (5 mg/ kg, ratiopharm, Ulm, Germany), and fentanyl 
(0.05 mg/kg b.w., Jannsen Cilag, Neuss, Germany) 15 minutes before tissue removal. 
After placement and fixation of a cannula (21G, Safety-Multifly®-Needle, Sarstedt, 
Nümbrecht, Germany) in the left ventricle the animal was perfused with 30 ml of 
physiological saline (NaCL 0.9%, B.Braun AG, Melsungen, Germany) over 1 minute and 
then 50 ml of 4% paraformaldehyde (PFA) (Morphisto GmbH, Frankfurt am Main, 
Germany) over 2 minutes using a pressure-controlled perfusion system (Perfusion One, 
Lecia Biosystems, Richmond, VA, USA). After carefully removing the brain it was placed 
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in a tube with 4% PFA at 4°C for 12-16 hours for fixation and then stored in phosphate 
buffered saline (PBS) until further preparation. 
 
2.7.2 Preparation and Staining of Brain Sections    
50 µm thick coronal sections were prepared using a vibratome (Leica VT1200S, Nussloch, 
Germany). After embedding the brain in 4% agarose (PEQLAB, VWR International GmbH, 
Erlangen, Germany) it was mounted on the stage of the vibratome, which was then set 
to the following parameters: 0.8 vibrating speed (amplitude) and 0.8 m/s advancing 
speed. Starting 1000 micrometers behind the olfactory bulb a total of 12 sequential 
coronal 50 µm thick sections were collected every 600 µm and applied to glass slides 
slides (ELKA, Glaswarenfabrik Karl Hecht GmbH & Co KG, Sondheim, Germany). The 
sections were then stained according to Nissl using cresyl violet (see Figure 12 for 
detailed protocol) and fixed and lidded (Eukitt®, O. Kindler GmbH & Co, Freiburg, 
Germany).  
 
2 min  Fix sections with 70% Ethanol 
10-15 min Cresyl violet solution 
 Rinse shortly with water (2 x) 
2 min Ethanol 70% 
2 min Ethanol 96% 
2 min Ethanol 100% 
2 min  Isopropanol 
5 min Rotihistol I 
5 min Rotihistol II 
 
Figure 12: Protocol for Nissl staining 
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2.7.3 Histological Quantification of Posttraumatic Brain Damage Parameters 
2.7.3.1 Evaluation of Defect Volume 
Gross pathology revealed that there is progressive tissue loss or defect formation in the 
zone of the former contusion as early as 7 days after trauma. Therefore, determination 
of contusion volume is not feasible at later observation time-points as there is no more 
contused/ necrotic tissue. In order to assess structural lesion size a different parameter 
for the groups that were observed from 7 days until 12 months after CCI was introduced: 
defect volume (Figure 13). Sections were placed under a microscope (Zeiss Axio Imager 
M2, Carl Zeiss Microscopy GmbH, Munich, Germany) and digitally photographed at 12.5 
X magnification with a digital camera connected to the computer (Zeiss Axio Imager M2, 
Carl Zeiss Microscopy GmbH, Munich, Germany). With the help of an imaging software 
(AxioVision LE 4.8, Carl Zeiss Microscopy GmbH, Munich, Germany), the areas of the 
contralateral hemisphere (A), ipsilateral hemisphere (B), and respective ventricle area (C) 
were measured. Defect area, i. e. the area of “missing tissue” was then calculated as 
based on the ipsilateral hemisphere, contralateral hemisphere and respective ventricle 
area:  
 
Defect Area = A – C –B (Figure 13).  
 
The defect volume was then determined using the following formula:  
VDir = d*(E1/2 + E2 + E3…+ En/2) with d = 0.6 (0.6 for 600 µm, distance between two 
sections).  
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Figure 13: Histomorphometric Determination of Defect Volume 
 
2.7.3.2 Determination of Tissue Atropy 
Quantification of tissue atrophy was also performed histomorphometrically (see 
description above for set-up). For determination of atrophy one section at 1.0 mm 
posterior the Bregma level (see Figure 14A [201]) was imaged and the area of both 
hemispheres determined (see Figure 14B for exemplary photograph). Atropy of the 
hemisphere ipsilateral to the trauma is expressed as percentage of contralateral 
hemisphere volume.  
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Figure 14: A. Schematic Drawing of a Mouse Skull [201]; B. Histomorphometric 
Determination of Atropy 
 
2.7.3.3 Assessment of Hydrocephalus  
Ventricular enlargement/ hydrocephalus was determined by histomorphometry at 1.0 
mm posterior the Bregma level (see Figure 15 for exemplary picture) [202]. The area of 
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the non-traumatized hemisphere and the hemisphere ipsilateral to trauma were 
measured. Results for both ventricles are given in mm2.  
 
 
 
Figure 15: Histomorphometric Determination of Hydrocephalus [202] 
 
 
2.7.3.4 Evaluation of White Matter Damage 
White matter damage was assessed by measuring corpus callosum thickness using 
hisomorphometry as previously described [202]. Corpus callosum width was determined 
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as shown in Figure 16 in both hemispheres in a section obtained at 1.0 mm posterior the 
Bregma level. Results are given in mm.  
 
 
 
Figure 16: Histomorphometric Determination of White Matter Injury [202] 
 
2.7.3.5 Evaluation of Hippocampal Damage 
For assessment of hippocampal damage one section 2.0 mm posterior the bregma level 
was imaged by histomorphometry. Total hippocampal area was then measured for both 
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hemispheres (Figure 17). Results are given hippocampal area for the ipsi- and the 
contralateral hemisphere. 
 
 
 
Figure 17: Histomorphometric Determination of Hippocampal Injury 
 
 
2.8 Statistical Analysis 
Statistical analysis was performed using a statistical software package (GraphPad Prism 
6.0, La Jolla, CA, USA). Sample size calculations were performed with the following 
parameters: alpha error = 0.05, beta error = 0.2, calculated standard deviation ranged 
from 15 - 20% (depending on the parameter investigated), and biologically relevant 
difference of 30%. As sample size is below 25 per group in our study we used 
non-parametrical tests even when data passed the normality test. For comparisons 
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between two groups the Mann–Whitney test was used, Kruskal–Wallis analysis of 
variance on ranks followed by Dunn’s method as a post hoc test was used to compare 
more groups. Differences between groups were considered significant at P<0.05. Except 
where indicated otherwise, all data are expressed as mean ± SD. 
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3. Results 
3.1 Behavioral Changes 
3.1.1 Body Weight  
Before surgery, there was not statistically significant different on body weight between 
the different groups (24.3 ± 1.1 g for the naïve group, 24.2 ± 1.2 g for the sham group, 
24.3 ± 1.1 g for the CCI group, n=10, each group). One day after operation, there was a 
significant loss of body weight in the CCI group as compared to naïve group (CCI group vs. 
naïve group p=0.0023), and there were no difference either between sham group and 
naïve group, or between sham group and CCI group. Animals in the sham and CCI group 
regained their pre-trauma body weight within 14 days after operation in (25.2 ± 0.9 g for 
the sham group, 24.8 ± 1.3 g for the CCI group). The weight of sham animals was 
reduced compared to naïve up to 270 d after operation. Over the observation period, 
the weight in naïve animals continuously increased up to 41.3 ± 1.9 g at 360 d. Sham 
animals showed a slight delay in weight gain but caught up with the naïve group at 360 d. 
After CCI, weight increased at a much slower rate for 360 d after trauma; animals were 
significantly lighter than the sham-operated or non-traumatized control group up to the 
end of the observation period (41.3 ± 1.9 g for the naïve group, 40.4 ± 2.3 g for the sham 
group, 34.4 ± 1.5 g for the CCI group; CCI vs. naïve, p<0.0001; CCI vs. sham, p<0.0001). 
Maximum body weight was significantly lower at all times (Figure 18).  
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Figure 18: Weight loss over time: After CCI and sham surgery, mice lose weight. In the 
further course of the experiment, CCI animals gained weight significantly slower than 
sham-operated mice which catched up with the non-traumatized group after 360 d; they 
had a reduced maximum body weight (n=10; *, CCI vs. naïve, p<0.01; #, CCI vs. sham, 
p<0.01).  
 
3.1.2 Motor Function – Beam Walk Test  
Before start of experiments there was no difference between groups as far as the time 
needed to cross the beam (11.3 ± 2.3 s for the naïve group, 10.2 ± 1.0 s for the sham 
group, 10.5 ± 1.6 s for the CCI group, n=10, each group, Figure 19A) or the number of 
missteps (0.5 ± 0.7 for the naïve group, 0.6 ± 0.8 for the sham group, 1.0 ± 0.9 for the CCI 
group, n=10, each group, Figure 19B) was concerned. 24 hours after surgery, animals in 
the CCI group needed significantly longer to perform the task than before TBI (109.3 ± 
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14.3 s vs. 10.5 ± 1.6 s, p < 0.0001) while no change was observed in the naïve and sham 
mice´s performance. Although CCI mice gradually recovered within a month they did not 
regain their pre-trauma level, crossing time was still significantly elevated compared to 
baseline (10.5 ± 1.6 s) at 360 days (20.3 ± 6.4 s) after CCI (p=0.0028); also, crossing time 
was significantly longer than in naïve (10.9 ± 2.5 s) and sham mice (11.4 ± 2.6 s) at 360 
days after CCI (CCI vs. naïve, p=0.0045; CCI vs. sham, p=0.0044). The results for the 
number of missteps showed a similar trend: there was significant worsening in the CCI 
group 24 hours after trauma (36.1 ± 4.0), compared to their own baseline (1.0 ± 0.9) 
performance (p < 0.0001), however, it remained stable throughout the observation 
period in the naïve group and sham group. Again, CCI mice gradually recovered within a 
month (9.8 ± 2.0), but their performance remained constantly worse than baseline (1.0 ± 
0.9), naïve (1.0 ± 0.9) and sham group (1.1 ± 0.9) at 360 d after trauma. (CCI vs. baseline, 
p < 0.0001; CCI vs. naïve, p < 0.0001; CCI vs. sham, p < 0.0001). 
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Figure 19: Motor Function assessed in the beam walk test. A. Time needed to cross the 
beam; B. Number of missteps. Directly after trauma there was a massive increase in time 
and missteps; the motor deficit recovers quite quickly but even after 6 months animals 
have not returned to their baseline value (n=10; *, CCI vs. naïve, p<0.01; #, CCI vs. sham, 
p<0.01). 
 
3.1.3 Depressive-like Behavior – Tail Suspension Test 
As described in the Materials & Methods section, tail suspension is a sensitive test 
paradigm that can detect depression like behavior; shorter mobility time is indicative for 
depression like behavior (Figure 20). Before the start of experiments there was no 
difference in mobility time among groups (33.0 ± 22.2 s for the naïve group, 31.0 ± 9.7 s 
for the sham group, 32.6 ± 7.4 s for the CCI group). Over the course of the experiment, 
mobility time declined in all groups, most probably due to habituation. However, 90 days 

45 

after trauma, animals in the sham group (12.0 ± 9.3 s) as well as the CCI group (13.3 ± 
15.4 s) showed shorter mobility time compared to naïve mice (27.0 ± 16.1 s) (sham vs. 
naïve, p=0.0522; CCI vs. naïve, p=0.0455). Mobility time steadily declined in CCI animals 
up to the end of the observation time at 360 d after trauma (0.156 ± 0.493 s), indicating 
progressive depressive behavior, and was significantly reduced compared to sham (9.84 
± 8.43 s) and naïve (12.3 ± 13.5 s) animals at the same time (CCI vs. sham, p<0.0001; CCI 
vs. naïve, p=0.0002). Sham animals recovered by 180 days after surgery and reached the 
levels observed in the non-traumatized group by the end of the observation period.   
 
 
 
Figure 20: Tail suspension test. Mobility time progressively reduced in mice after TBI 
indicating depression like behavior (n=10; *, CCI vs. naïve, p<0.01; #, CCI vs. sham, 
p<0.01). 
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3.1.4 Spatial Orientation and Learning Behavior - Barnes Maze Test 
Figure 21A shows representative summary heat maps obtained at 360 d after trauma. 
Starting 90 days after trauma, latency (Figure 21B), distance (Figure 21C), and mean 
velocity (Figure 21D) was investigated every 90 days. Latency was significantly elevated 
in the CCI group (65.03 ± 38.97 s) 90 d after TBI compared to sham operated (12.76 ± 
10.20 s) or naïve animals (13.60 ± 9.946 s) at the same time (CCI vs. sham, p<0.0001; CCI 
vs. naïve, p<0.0001). Over the course of time, performance in the CCI group operated 
deteriorated up to the end of the observation period at 360 d after trauma (129.7 ± 
66.01 s) and was significantly worse than that at 90 d after trauma (p=0.0277). While the 
naïve operated (16.39 ± 9.349 s) and sham operated (18.70 ± 13.23 s) group presented 
stable latency times at 360 d and significant better than the CCI group (CCI vs. naïve, 
p=0.0002; CCI vs. sham, p=0.0002). This indicates that there is progressive memory loss 
in TBI. Distance was constantly and significantly higher in the CCI group (260.7 ± 116.1 
cm) compared to the naïve (137.4 ± 73.67 cm) and sham group (142.5 ± 104.1 cm) at 360 
d (CCI vs. naïve, p=0.0147; CCI vs. sham, p=0.0288), and the mean velocity was lastingly 
and significantly lower in CCI (2.952 ± 2.751 cm/s) compared the naïve (8.928 ± 1.837 
cm/s) and sham group (8.131 ± 2.206 cm/s) at 360 d (CCI vs. naïve, p=0.0007; CCI vs. 
sham, p=0.0007). 
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Figure 21 Barnes Maze Test. A. Summary heat maps for all groups obtained at t=360 d; B. 
Quantification of latency: CCI animals need significantly more time to correctly identify 
the home cage; C. Quantification of distance: CCI animals need significantly more 
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distance to correctly identify the home cage; D. Quantification of mean velocity: CCI 
animals showed significantly less velocity to correctly identify the home cage (n=10; *, 
CCI vs. naïve, p<0.01; #, CCI vs. sham, p<0.01). 
 
3.2 Histopathological Changes 
3.2.1 Defect Volume   
Gross histopathological exam showed that the posttraumatic lesion significantly 
enlarged over time (Figure 22A). At 7, 30, 90, 180 or 360 days after CCI the defect 
volume significantly expanded from 16.28 ± 1.417 cm3, 19.67 ± 5.825 cm3, 21.44 ± 2.752 
cm3, 27.62 ± 4.586 cm3 , and 33.31 ± 2.614 cm3 on day 7, 30, 90, 180, and 360 
respectively (Figure 22B, 7 d vs. 360 d, p=0.0079). 
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Figure 22: A. Gross histopathology in different groups and different time points; B. 
Defect Volume. Defect volume significantly increased over time reaching a maximum at 
360 d (n=5; #, p<0.01). 
 
3.2.2 Hemispheric Atrophy  
The atrophy was described by the ratio of traumatized hemispheric volume / 
non-traumatized hemispheric volume (%). The traumatized hemisphere undergoing 
significant atrophy over time decreased to 83.16 ± 1.308 %, 77.88 ± 5.949 % , 78.22 ± 
2.325 %, 74.30 ± 4.860 %, and 67.69 ± 2.946 % on day 7, 30, 90, 180, and 360 
respectively (Figure 23, 7 d vs. 360 d, p<0.0001). There was no change in naïve and sham 
group till 360 d. 
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Figure 23: Hemispheric Atrophy. The traumatized hemisphere was undergoing significant 
atrophy over time (n=5; #, p<0.01). 
 
3.2.3 White Matter Injury – Corpus Callosum Thickness  
Thickness of the corpus callosum ipsilateral to the traumatic lesion progressively 
decreased over time (see exemplary section in Figure 24A) and was significantly reduced 
compared to the contralateral hemisphere on 180 and 360 days after CCI (p=0.024, 
p=0.007, respectively, Figure 24B).  
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Figure 24: A. Exemplary section obtained 360 d after trauma; B. Quantification. Corpus 
callosum width decreases over time and this was more pronounced in the traumatized 
(ipsilateral) hemisphere (n=5). 
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3.2.4 Hydrocephalus  
Ventricle enlargening in the traumatized hemisphere was observable till 360 d after CCI 
(see Figure 25A for exemplary section). Over time, there was progressive increase of the 
size of the lateral ventricle of the traumatized hemisphere. The progressive ventricle 
area ratio (ipsilateral / contralateral) indicates increasing asymmetrical hydrocephalus 
(Figure 25B).  
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Figure 25: A. Exemplary section at 360 d after trauma; B. Quantification. Over time, 
there was progressive ventricular enlargening of the lateral ventricle on the traumatized 
(ipsilateral) hemisphere (n=5). 
 
3.2.5 Hippocampal Damage  
Hippocampus damaged in the traumatized hemisphere was observable after CCI (see 
Figure 26A for exemplary section). There was a significant loss of hippocampal tissue in 
the traumatized hemisphere which was progressive over time (Figure 26B). Significant 
reduction of ipsilateral hippocampal area presented as early 7 days after CCI ( p<0.0001) 
and aggravated over time reaching a maximum 360 days after CCI (7 d vs. 360 d, 
p=0.0069). For the non-traumatized hemisphere, the hippocampus also changed from 7 
d to 360 d after trauma (7 d vs. 360 d, p=0.0043). 
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Figure 26: A. Hippocampal damage exemplary slides demonstrating hippocampal defect 
in the traumatized hemisphere after 360d after CCI; B. Over time, there was progressive 
hippocampal defect on the traumatized (ipsilateral) hemisphere (n=5).  
 
3.3 Summary of Results 
Experimental TBI led to progressive behavioral and histopathological changes. There was 
a sustained impairment of the general condition as evidenced by stunted weight gain 
persisting for up to 12 months after single TBI. Motor function was most severely 
affected in the first few weeks after trauma; animals then recovered quickly but 
revealed significant deficits up to the end of the observation period. By contrast, 
depression like symptoms and memory deficits were observable early after trauma but 
then progressively deteriorated, reaching a maximum at 12 months after TBI. On a 
histolpathological level, after resorption of acute changes in the contused area, there 
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was progressive tissue loss leading to an expansion in defect volume, incremental white 
and grey matter atrophy of the traumatized hemisphere, and increasing ventricular 
enlargening, consistent with hydrocephalus. These histopathological changes most 
probably are the pathophysiological correlate for the observed progressive 
neurocognitive deterioration.  
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4. Discussion 
4.1 Discussion of the Method 
4.1.1 Selection of the experimental animal species 
The experimental animals chosen for the present study were male C57Bl/6 mice. Mice 
are the most common experimental animal models used for traumatic brain injury 
studies because they have a number of advantages when compared to rats: firstly, they 
can be quickly and inexpensively bred due to their short reproduction cycle, secondly, 
they offer the possibility of breeding of genetically modified strains. As for the CCI model, 
our laboratory has vast experience in performing these experiments in mice [97, 105, 
110, 111, 113, 138, 194-196, 203-212], therefore it is possible to compare the present 
data with results obtained by various researchers in the past. We chose to perform this 
study in young adult male mice as endogenous production of estrogens and 
progesterone in female mice may influence secondary brain damage and outcome after 
experimental traumatic brain injury and therefore have a significant impact on our 
observations [52, 213, 214]. As this is the first study of its kind we primarily wanted to 
establish the nature and time-course of long-term changes after traumatic brain injury; 
of course, these findings need to be validated in female and aged animals at a later time 
point. Another important concern of the mouse model is the animal´s small body size 
which makes surgical manipulation and preparation more challenging. However, this can 
be overcome by the intraoperative use of surgical microscopes, microsurgical techniques 
and adequate surgical training. Also, neuropsychological testing is difficult in mice; this is, 
however, not restricted on rodents but true for all animal experiments. For this study 
three well-established paradigms were chosen (see chapter 4.1.4 for a more thorough 
discussion of this topic). The metabolism of pharmaceuticals in mice can be considerably 
different from that of humans [215, 216]; as the present study uses a purely 
observational approach without pharmacological intervention, however, this possible 
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disadvantage of the mouse model does not apply to the current study. Considering all 
disadvantages and advantages, we think that the mouse model selected as experimental 
animal is adequate and suitable for the purpose of the present project.  
 
4.1.2 Selection of the traumatic brain injury model 
As traumatic brain injury is a complex disease with many cerebral and extracerebral 
parameters influencing lesion development and outcome it is unrealistic that one 
experimental model will adequately reproduce all relevant factors pertaining to TBI 
pathophysiology. Some patients sustain TBI in the context of multiple/multi-organ 
trauma [217]; as the aim of the present study was to evaluate the effect of head trauma 
only we chose a model of isolated head injury. Over the years, many different 
experimental models for the study of traumatic brain injury pathomechanisms have 
been developed [218-220], each with specific advantages and disadvantages. When 
choosing a model for an experimental study it is therefore important to consider each 
model´s characteristics and its suitability for the intended scientific purpose.  
In the present study, the controlled cortical impact model was used. The CCI model has 
been routinely performed in our laboratory for more than 15 years [105, 110, 111, 113, 
117, 138, 194, 203, 205, 206, 208, 209, 211, 212, 221, 222]. All parameters determining 
contusion size (e.g. impact depth, impact velocity, and dwelling time) can be chosen and 
adjusted separately and accurately therefore inducing a highly reproducible lesion, a 
high level of standardization, and high inter- and intra-observer stability. In the present 
study, an impact depth of 1 mm, an impact velocity of 8 m/s, and a dwelling time of 150 
milliseconds was selected as these parameters result in a midsized to large contusion 
with a well quantifiable secondary lesion expansion of approximately 60% of the initial 
tissue lesion [105, 110, 194, 203, 212, 221] which mirrors the situation found in patients 
with traumatic cortical contusions [26]. Furthermore, animals subjected to CCI show 
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distinct neurological deficits after trauma that persist (and may therefore be quantified) 
while having a low mortality rate [194, 212]. CCI has been successfully used not only in 
rodents (rats [223-225], mice [226-229], ferrets [193, 230]), but also in large animal 
models (swine [231-233], non-human primates [234]) where pathophysiology was 
similar and comparable to small animal experiments. CCI mainly leads to contusional 
brain damage which is a very important component of human TBI pathophysiology [74]. 
Other damage patterns such as diffuse axonal injury do not occur regularly in CCI. 
However, CCI leads to a variety of well-defined and well-quantifiable secondary 
phenomena such as intracranial hypertension [105, 194, 203, 221], cerebral ischemia 
[138], and brain edema formation [47, 105, 212, 222] which are crucial mechanisms for 
secondary brain injury in humans [88, 235].  
The free weight drop model developed by Marmarou et al. predominantly causes diffuse 
axonal injury and hippocampal cell death [236, 237]. In this model, brain injury is 
induced by dropping a defined weight which is enclosed in a glass tube from a certain 
height onto the exposed skull protected with a metal disk. This model may be adjusted 
and changed in severity by changing the drop height and the weight used. Disadvantages 
include: re-hits [238], and lack of fixation [239]. Another widely used model for TBI is the 
fluid percussion injury (FPI) model. In FPI, the traumatic lesion is induced by a pendulum 
that impacts a fluid-filled tube placed over the epidural space after craniotomy [240, 
241]. The impact may be applied lateral or para-sagittal (central) [242]. The mechanical 
forces disrupt cell membranes, blood vessels, and neuronal processes, and may also lead 
to subarachnoid/intraparenchymal hemorrhage. Thus, FPI is widely used in experimental 
TBI research because it replicates clinical contusion without skull fracture. However, the 
FPI model also has some limitations, such as restricted biomechanical control and 
inability to reflect the entire complexity of human TBI. This prompted the search for 
alternative TBI models [243]. Considering all the points mentioned above, we decided to 
use the CCI technique because of our interest in the pathophysiology of contusions, the 
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high reproducibility of the CCI model, and its adequate modelling of a majority of 
pathophysiological factor relevant to human traumatic brain injury. 
 
4.1.3 Histological analysis (Necrosis Volume, Defect Volume, Hydrocephalus, White 
Matter Injury, and Hippocampus) 
There are various methods for the calculation of lesion volume and other parameters of 
parenchymal injury in experimental TBI. In the present study, we used a histological 
approach (using 50 µm floating sections) to determine the extent of tissue damage 
induced by experimental TBI. This evaluation method is highly precise, can be 
inexpensively performed and does not require specialized infrastructure. Our group has 
been working for many years with Nissl staining proving that a very high quality standard 
in the production of tissue sections, high diagnostic accuracy, and low inter-researcher 
variation can be achieved [105, 194, 212, 222, 244]. Because infiltrating inflammatory 
cells harbor intact mitochondria, tetrazolium chloride (TTC), a widely employed and 
easily to use mitochondrial vital stain should not be used for time points beyond 24 
hours after injury because injury volumes may be underestimated [245, 246]. 
Accordingly, Nissl staining may be the most accurate method for the purpose of the 
current study. 
In recent years, CT or MRI is increasingly used in order to evaluate lesion size. The major 
advantage of radio-morphological quantification of brain injury is that it may be 
performed repeatedly in on animal allowing to track the lesion over time while all 
histological methods require to sacrifice the animal. With MRI, it is furthermore possible 
to determine not only the lesion volume but it also offers the possibility to evaluate 
cerebral blood flow and brain edema at the same time [247, 248]. However, the 
evaluation of the MRI data is hindered by pronounced inter-individual variation. Also, it 
may be difficult to reach the high resolution necessary for the exact determination of 
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lesion size – especially in mice - , as technical problems can negatively impact image 
quality and – thus – the feasibility of exanimation. Furthermore, no standardized 
examination conditions are available yet, so the comparability of results is difficult [249]. 
It therefore remains unclear what constitutes necrosis /lesioned tissue, because damage 
areas in MRI imaging are not exclusively comprised of necrosis alone, but are also 
influenced by other factors such as brain edema formation [249]. Some studies show 
progressive T2-alterations at the lesioned hemisphere [168, 250] but it remains unclear 
what the exact structural correlate of this alterations is. Therefore, the lesion detected 
by MRI may not be exclusively necrotic, which is a major disadvantage compared to 
histological evaluation used in the present study. Lastly, animals need to be anesthetized 
repeatedly for the scans which may influence the development of a chronic lesion [251]. 
In the present study we therefore used histological methods to quantify structural brain 
damage as this allowed the most exact determination of tissue damage and other 
parameters of chronic traumatic brain damage even though this meant to use a higher 
number of animals.  
In the present study, we also evaluated other features commonly occurring after TBI in 
patients that may significantly influence outcome and quality of life [168, 252-254]: 
hydrocephalus [255], white matter injury [256], and hippocampal damage [257].  
Posttraumatic hydrocephalus (PTH) is defined as an active distention of the ventricular 
system within the brain related to inadequate passage of CSF from its point of 
production within the ventricular system to its point of absorption into the systemic 
circulation [255, 258], and is a frequent pathological finding after TBI [259]; its incidence 
has been estimated to be as high as 45% [151] of patients examined between 3 and 12 
months after TBI [260]. Lateral ventricular enlargement in patients has been associated 
with memory deficits [261], and is considered a predictor for cognitive decline after 
brain injury [261]. Ventricular enlargement is an obvious structural biomarker of TBI [253] 
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which can be precisely quantified in brain sections [167, 202, 262, 263], as previously 
proven by our laboratory [202] (see chapter 4.2.2.4). 
Clinical and experimental data indicate that after TBI progressive white matter damage 
occurs preferentially in the corpus callosum and the external capsule and is associated 
with axonal pathology in both hemispheres [167, 168, 191, 262, 264]. Atrophy of the 
corpus callosum is present in 63–86% of severe TBI patients 5 and 20 months after injury 
[265, 266]. Previous studies showed that the extent of damaged white matter increases 
with the severity of TBI [267, 268]. The width of corpus callosum is an indicator for the 
level of white matter injury [202] and it may be exactly quantified in coronal histological 
sections [202].  
Lastly, we assessed the extent of neuronal damage in the hippocampus. Hippocampal 
change is one of the most common findings in TBI patients [254, 268-270], and this 
damage pattern is thought to be associated with memory loss [271, 272], and mood 
disorders [273]. Previous experimental and clinical studies showed that neurons in the 
hippocampus are highly vulnerable to TBI [262, 269, 274] and that extent of 
hippocampal damage increases with injury severity [275]. We therefore decided to 
quantify hippocampal damage histologically in the present study.  
 
4.1.4 Determination of Neurological Outcome (Beam walk, Tail suspension, Barnes 
maze) 
As mentioned above neurological testing is challenging in all experimental animals 
models, especially those in mice. In the present study we focused our neurological and 
behavioral evaluation on three areas that are commonly found after TBI and significantly 
affect patients´ quality of life: motor/gait disturbances [276], depressive behavior [277] 
and neurocognitive dysfunction such as memory deficits [278]. For this, we chose three 
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well established test paradigms: the beam walk test [279-281], the tail suspension test 
[282], and the Barnes Maze test [283].  
The beam walk test has been widely used to evaluate motor balance and coordination in 
mice [279-281, 284]. The test paradigm is easy to learn, the setup inexpensive, and the 
evaluation by camera cam be standardized very well. Therefore the beam walk test has 
been shown to have a high reproducibility and a low inter-observer variability after CCI 
[110, 194, 285]. The test is very sensitive in diagnosing subtle deficits in motor function 
that may not be detected by other motor tests, such as the Rotarod test [286], cylinder 
test [287], and grid walking test [288]. The Beam walk test is more sensitive to detect 
misplacements of the hindpaw, however, the grid walking test is more sensitive to 
forelimb deficits [289]. Considering these points we selected the Beam Walk test 
because our CCI model affects mainly the function of hindpaw in mice. 
Depression is a heterogeneous, multifaceted disorder. Many of the diagnostic features 
used in humans (e.g. recurring thoughts of death or suicide), however, can for obvious 
reasons not be investigated in mice. In order to assess depressive behavior in rodents, 
several test paradigms were developed. The forced swim test (FST) is probably the most 
widely used method in preclinical depression research [290-292]. For this test, the 
mouse is put in a tank filled with water and observed for a certain period of time; the 
physiological response is vigorous swimming. Immobility is considered a sign of reduced 
impetus and depressive behavior, the time spent immobile has been shown to 
correspond to the level of depression. However, immobility in this test may be 
influenced by body cooling which is dependent on the temperature of the water [293]. 
While well established, the test is seen critical by some ethics´ committees and judged to 
be very stressful for the animals, also by the government of Upper Bavaria, the agency 
responsible for approval of all animal experiments in our university. Therefore, 
alternatives were developed. The tail suspension test was introduced as a new model for 
testing anti-depressant compounds in 1985 [198]. For this test, animals are suspended 
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by the tail, then, as in the FST, mobility and immobility time are assessed over a period 
of 2 minutes. Immobility/mobility time conforms to depression like behavior. The test is 
well validated and the correlation with depression-like behavior is solid. Compared to 
the FST, it is easier to perform, may be done in up to three animals at a time, test 
conditions can be better controlled, and there is no risk of hypothermia due to 
submersion in water [294]. Given these advantages this test paradigm was chosen for 
the present study.  
Analogous to depressive behavior, cognitive deficits are difficult to detect and quantify 
in experimental animals, especially in rodents [105, 203, 295-297]. Maze tests like the 
Morris Water Maze (MWM) or Barnes Maze test evaluate whether the experimental 
animals is able to memorize the location of its home-cage. In case of the water maze, the 
home-cage is an elevated platform that is placed in a basin filled with opaque water. The 
MWM was designed by Richard G. Morris in 1981 [298] and later adapted to evaluate 
spatial learning [299]. The animal is put in the middle of the tank and - after an adequate 
training phase – is quickly able to swim to the platform. After cerebral insults animals 
take longer to reach the platform as they have problems remembering its location; the 
distance travelled and the speed of swimming are tracked with a camera, then assessed 
automatically and are correlated to memory loss [300]. Ennaceur and Delacour 
subsequently developed the Object Recognition Test (ORT) which is based on the natural 
propensity of rats to explore novel objects [301]. For this test, animals are placed in a 
cage with two identical objects; subsequently one of the objects is replaced with a new 
object in a second session. The ORT is a method to assesses whether an object is 
recognized or it is considered "new" by the animals [301]; the time spent exploring the 
changed/new object is considered a measure for recognition and memory function. 
Different species react differently in the same test, therefore results of the ORT in rats 
cannot be considered to equal those obtained in mice [302]. Compared to the MWM, 
the ORT does not require training or food restriction [303]. The disadvantages of the ORT 
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include non-specific and confounding factors that can affect object exploration times 
[304]. The Barnes Maze was developed by Dr. Carol Barnes in 1979 [283] and is also 
regarded as a dry-land version of MWM. As described in chapter 2.6.3, animals were put 
onto a disk (diameter 100 cm) with 20 identical holes (diameter 10 cm). Scent cues left 
on the maze by the previous animal may influence the performance of subsequent 
animals. This, however, can be easily corrected by cleaning the maze after each trial. 
Various parameters may be analyzed in order to assess the spatial memory such as 
latency, mean velocity and total distance [305]. Latency, path length to escape box, and 
number of errors to the first nose poke at the escape hole have been used as measures 
previously [306, 307]. Thus, measurement of multiple parameters, including latency, 
error rate, velocity, total distance, and search strategy, may collectively provide a better 
indicator of each subject's spatial navigational learning and memory ability [308, 309]. 
Because the path to target is in no way constrained, the escape latency is the most 
important parameter which is dependent on different coping strategies used to 
overcome memory deficits [305, 307, 310]. The mice were repeatedly exposed to the 
test which may lead to habituation and affect the test performance, therefore the test 
was performed every 90 days only. A major problem of all cognitive tests is that the 
observed endpoint in these test paradigms is not entirely dependent on neurological 
functions alone but may also be influenced by motor deficits in the case of Maze tests. In 
order to better standardize the test and make it more reliable, automated evaluation 
systems are applied. In the present study, we used the Noldus EthoVision®XT tracking 
system, which is the most widely used video tracking software that tracks and analyzes 
behavior, movement, and activity of animals [311]. It is an effective solution for all 
standard behavioral tests such as the MWM and open field testing and can be combined  
with sophisticated test-protocols.  
Memory tests results may be influenced by many factors such as hypothermia after the 
MWM test [312]. The most frequently disadvantage of the MWM is that it is overly 
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stressful which may negatively impact test performance [313] and therefore be avoided 
[314]. The Barnes maze is considered less stressful and less energy-consuming for mice 
than the MWM [315] even though stress and/or anxiety cannot be completely prevented 
[316]. However, considering all factors, the Barnes maze seems the most adequate 
testing method for the present study.  
 
4.2 Discussion of the Results 
4.2.1 Neurological and behavioral changes after TBI  
4.2.1.1 Motor/ physical deficits/ body weight after traumatic brain injury 
In TBI patients motor deficits are common after severe TBI [317]. Severe motor function 
often improve until sixth weeks after TBI, however, deficits may persist for years [318]. 
In the present study, severe motor deficit persisted for up to 12 months after trauma in 
TBI animals compared to non-traumatized and sham-operated animals. As previously 
shown, severe motor deficits were present on the acute phase of TBI, and recovered 
over time after experimental TBI [110, 319, 320]. Interestingly, while the massive 
increase in missteps observed after CCI was quickly declining within 7 days, traumatized 
animals then reached a plateau phase with a slight, but significant level of motor 
impairment/gait disturbance which then persisted throughout the observation period 
and did not recover even one year after trauma. In clinical studies, almost 25% of 
patients with TBI suffered from motor problems [321] within the first year after injury 
[322]. Our results were similar to those of Pischiutta et al. who showed that for the first 
three months after trauma the number of missteps increased between 3 and 12 months 
after TBI, however, the authors argued that motor deficits were artefactual due to 
weight gain of the animals [168]. Recent studies reported that in the chronic stage after 
TBI the increase in body weight and longer inter-test intervals may be related to a 
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worsening in performance in the beam walk test [168, 323-325]. However, in our study, 
body weight was recorded over time in all groups and we did not detect any correlation 
between motor function and body weight in traumatized, non-traumatized or 
sham-operated animals. Therefore we think that weight gain is not a confounding factor 
in our analysis.  
Also aging was discussed to be a possible reason for declining long-term motor function 
due to declining muscular strength and/or neuromuscular function [326, 327] and may 
therefore be a reason for deteriorating performance in the beam walk test over time 
[326, 328]. However, we did not detect changes in the control groups so this seems to be 
a negligible confounder in our study.  
In summary, we did not find any significant aging or body weight effect in our control 
groups so we think weight gain and/or a significant aging effect may be excluded as 
causes for the differences observed in motor function over time after TBI and that the 
changes detected are solely due to traumatic brain injury. 
 
4.2.1.2 Behavioral changes after TBI 
Psychiatric disorders such as depression [329], mania [329], and posttraumatic stress 
disorder [330] occur frequently after TBI and significantly impact patients´ quality of life 
[329, 331, 332]. Depression is one of the most common psychiatric disorders observed 
after TBI [333]; it affects more than half (52%) of patients within the first year after head 
injury [334]. More than one third (33–42%) of all depressive episodes after TBI occur 
within the first year after injury [277, 335], and almost two thirds (61%) are diagnosed 
within the first seven years [336]. The risk of developing depression is not only 
associated with moderate and severe TBI, but is increasingly recognized to also correlate 
with mild TBI [331, 337]. On an anatomical and pathophysiological level, development of 
depressive symptoms is correlated with disturbances/lesions in frontal lobe, basal 
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ganglia, and anterior ascending monoaminergic pathways [338, 339]. Focal and diffuse 
traumatic injury in the dorsolateral frontal, temporal, and/or left basal ganglia have been 
associated with onset of depression [277, 340-342]. The lesion in our model was 
increasingly affecting these brain regions over time therefore providing an anatomical 
explanation for the progressive depressive behavior observed in our experimental series. 
In experimental TBI, previous studies showed that CCI or closed head injury of varying 
intensity and severity induced depression-like behavior (as measured with the forced 
swimming test) till day 90 after trauma [343-346]. Interestingly, the development of 
symptoms was independent of the severity of TBI [343]. Bajwa et al. reported no 
difference between sham-operated and CCI mice 90 days after trauma [347], however, a 
non-traumatized control group was missing. In our study, we did also not detect a 
difference between traumatized and sham-operated mice until 90 days after TBI. Later 
sham operated mice recovered and reached the levels observed in the non-traumatized 
animals 180 days after surgery. A similar behavior was also observed by others using 
diffuse TBI models [285, 348, 349].  
In our experiments the mobility time declined in all groups over time. This may be 
caused by habituation [350], however, since all traumatized mice were completely 
immobile at the end of the observation period 360 days after TBI as compared to naïve 
and sham-operated animals , we conclude that depression-like behavior was indeed 
caused by the expanding traumatic lesion and cannot be solely ascribed to habituation.  
 
4.2.1.3 Neurocognitive disorders after traumatic brain injury 
Cognitive deficits such as memory impairment [167, 351], reduced attention span, and 
working memory deficits [352] are the most common neurological manifestations 
observed after TBI and are significantly more frequent than physical impairments [353]. 
These symptoms are often long-lasting and increasing in severity and have a significant 
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impact on the quality of life of TBI patients [353, 354]. 42% of patients who suffered 
severe TBI report cognitive deficits as early as three weeks after injury [354]. A 
systematic review of 33 studies shows that moderate-to-severe TBI is associated with 
cognitive deficits that last six months or longer post-injury [355]. After experimental TBI, 
cognitive deficits are most commonly evaluated by MWM or Barnes maze [199, 356]. 
Using these test paradigms, it was shown that there is significant acute impairment of 
spatial learning and memory in animals subjected to traumatic brain injury two days 
after trauma [356]. These deficits may persist for at least one year after trauma in 
rodents [168, 263, 357-360]. We chose the Barnes maze testz to evaluate memory 
functions after trauma (see chapter 4.1.4). Significant deficits were observed as early as 
90 days after TBI compared to non-traumatized and sham-operated animals; later on  
performance continuously and progressively deteriorated. This is consistent with other 
reports that evaluated mice at 12 months after experimental TBI [167, 263]. Others  
reported that mice showed an improvement of learning ability over time after TBI, 
however, memory retention deficits persisted for at least 6 months after injury [168]. 
While this may be due to declining stress/anxiety responses with habituation [316], 
authors speculate that this partial recovery may be related to remodeling of surviving 
neurons [361].  
In our experiments incremental neurocognitive changes were associated with significant 
histopathological changes, namely progressive brain atrophy and hippocampal damage. 
We assume that general loss of brain tissue and progressive hippocampal damage are 
the most probable correlates for the progressive cognitive changes we observed. As 
previously shown in patients, a history of TBI represents a high risk for the development 
of dementia [362]. More and more clinical studies show that (even a single) trauma may 
produce progressive histopathological changes in the brains of affected patients who 
may deteriorate over a long period of time. This phenomenon was mainly described in 
athletes with a long history of repetitive brain injury such as American football players, 
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and boxers [363]. Damage to and atrophy of prefrontal cortex and temporal lobe are 
related to the development of cognitive deficits after TBI [364]. In patients symptoms 
vary with lesion extent and location, however, in experimental studies, where lesion are 
much more homogenous, memory deficits clearly correlated with injury severity [365]. 
Especially hippocampal atrophy (which may also occur during normal aging) is associated 
with the development of mild memory deficits [366]. Hippocampal damage may 
therefore be a significant risk factor for cognitive deficits [367, 368]. This is also 
supported by our results which show that progressive deterioration of memory function 
up to 12 months after trauma is associated with progressive hippocampal damage. 
 
4.2.2 Morphological and Histopathological Changes after traumatic brain injury 
4.2.2.1 Lesion/ defect volume 
In the present study, we show that a single TBI triggers progressive neuropathological 
changes mainly in the traumatized hemisphere. We evaluated several parameters of 
chronic brain damage, defect volume, hemispheric atrophy, corpus callosum thickness, 
ventricular enlargement, and hippocampal size in the ipsilateral hemisphere to 
investigate and characterize these neuropathological changes. Our current model 
produces a substantial focal lesion, with a defect volume that doubles over the course of 
the experiment, continuously increasing from about 16 mm3 on day seven to 33 mm3 12 
months after trauma. These results are well in line with results obtained by Dixon et al.  
in rats, who compared histopathological outcome three weeks and one year after CCI 
[263]. Loane et al. demonstrated expanding lesion volumes over time in mice using 
repetitive MRI scans up to one year after CCI. The significance of these findings, however, 
remained unclear since contusions evaluated by histological analysis 12 months after TBI 
were much smaller than the lesion quantified by MRI [250]. In our study, the traumatic 
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tissue defect is deeper and more extensive, mainly because it comprises not only 
contused cortex, but also white matter [191, 263]. This may be the explanation why in 
our study progressive loss of brain tissue was associated with progressive functional 
deficits.  
 
4.2.2.2 Hippocampal damage 
A decrease of hippocampal volume correlates with the occurrence of memory deficits 
[261], and hippocampal damage is one of the most common consequences of TBI [369]. 
While hippocampal lesions can impair both spatial and non-spatial tasks, spatial memory 
is almost exclusively dependent on proper hippocampal function [367]. MRI data 
following experimental TBI showed that the reduction of ipsilateral hippocampal volume 
occurred from one day until one year after CCI [168]. In the present study, there was a 
significant loss of hippocampal tissue in the traumatized hemisphere which was 
progressive over time. Interestingly, also the hippocampal volume in the 
non-traumatized hemisphere decreased from 7 d to 12 months after trauma. These 
changes resulted in memory deficits as also shown by others [366]. Hippocampal 
damage may therefore be a significant risk factor for cognitive deficits in TBI patients 
[367, 368]. 
 
4.2.2.3 Ventricular enlargement/posttraumatic hydrocephalus (PTH) 
PTH is defined as an active distention of the ventricular system within the brain related 
to inadequate passage of CSF from its point of production within the ventricular system 
to its point of absorption into the systemic circulation [255, 258] and is a frequent 
pathological finding after TBI [259]. The incidence of PTH has been estimated to occur in 

71 

up to 45% of TBI patients [151, 260]. Possible reasons are reduced CSF resorption 
(Hydrocephalus aresorptivus), blockage of CSF pathways (Hydrocephalus occlusus), or 
cerebral atrophy [151, 370]. Lateral ventricular enlargement in patients has been 
associated with memory deficits [261] and is considered a predictor for bad 
cognitive outcome after brain injury [261]. Ventricular enlargement is also common in 
experimental TBI and has been detected up to one year after injury [191, 250, 263, 270]. 
Experimental studies observed enlargement of the ipsilateral lateral ventricle between 
one month and one year after injury [191, 262, 263]. In the current study we were able 
to show that progressive ventricular enlarging of the lateral ventricle on the traumatized 
(ipsilateral) hemisphere started as early as 7 days after injury and continued for 12 
months, the time when the ventricle merged with the traumatic lesion (at 1.0 mm 
posterior the Bregma level). Together with brain atrophy and hippocampal damage 
progressive PTH may be another reason for progressive cognitive loss after TBI since PTH 
is well known to cause such changes in patients [150, 253]. 
 
4.2.2.4 Hemispheric atrophy  
In TBI patients parenchymal atrophy starts three weeks after moderate to severe brain 
injury and reaches its maximum 8–12 months later [371-373], findings which were 
confirmed by experimental studies [191, 263, 270]. The most pronounced atrophy was 
observed in cortex, hippocampus, thalamus, and septum [191]. Smith et al. showed that 
progressive post-traumatic atrophy is found up to one year after trauma [191]. In 
keeping with previous similar results up to one year after FPI [191, 270], the present 
study demonstrates that the traumatized hemisphere underwent significant atrophy 
over time. Some studies demonstrated relationships between cognitive outcome and 
degrees of atrophy after TBI [188, 374]. However, the mechanisms of persistent 
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cognitive deficits and their relationship to progressive tissue atrophy after TBI are 
unclear and merit further investigation [263].  
 
4.2.2.5 White matter atrophy/ corpus callosum degeneration 
Six weeks after TBI 30% of patients display degeneration of white matter tracts [372, 
375]. White matter seems to be particularly vulnerable to chronic degeneration after 
[353, 376] since progressive white matter volume loss has been shown to continue up to 
4 years after TBI [263, 377]. Further on white matter damage is an important 
determinant of cognitive deficits after TBI [378]. Little is known about the temporal 
dynamics of white matter damage after single experimental TBI. One recent study using 
repetitive MRI (diffusion tensor imaging, DTI) in a mouse model of single CCI trauma 
showed evidence for progressive white matter damage spreading from the ipsilateral to 
the contralateral hemisphere starting 6 months after a single focal CCI injury and 
increasing up to 12 months after TBI [168].  
In our study, thickness of the corpus callosum ipsilateral to the traumatic lesion 
progressively decreased over time and was significantly reduced compared to the 
contralateral hemisphere 180 and 360 days after CCI, but the corpus callosum of the 
contralateral hemisphere was not affected up to 360 days after CCI. This is not in line 
with the results of the study of Pischiutta et al., however, in their study white matter 
changes were investigated by MRI, a method which may overestimate tissue damage 
(see above).   
 
4.2.3 Conclusion 
CCI led to a significant and progressive reduction of body weight, motor function, and 
memory and caused depressive-like behavior. The volume of tissue loss increased 
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continuously over time and reached a maximum 360 days after CCI. Histopathology 
revealed progressive atrophy of the ipsilateral hemisphere, of ipsilateral white matter 
tracts, and of the ipsi- and contralateral lateral hippocampus. A significant and increasing 
enlargement of the ipsilateral lateral ventricle was detectable, consistent with 
progressive hydrocephalus formation. Hence, the present study provides a 
comprehensive overview of the histological and neurocognitive long-term sequels of a 
single focal brain injury and may therefore serve as an important basis study for future 
investigations into the mechanisms of progressive post-traumatic brain injury. 
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5. Summary and conclusion 
5.1 English summary 
Traumatic brain injury (TBI) is a major public health problem in developed as well as 
developing country. In past decades, clinical and pre-clinical research efforts focused on 
the acute, life-threatening pathophysiological events after TBI. Previous research 
showed that TBI is a risk factor for cognitive decline. The aim of the present study was to 
characterize the development of chronic neuropathological and neurobehavioral 
changes in a widely used mouse model of TBI, controlled cortical impact (CCI) injury, 
over a period of 360 days. Male C57BL/6N mice (n = 10 per group) underwent CCI or 
sham operation and were observed together with naïve animals for 15 min, 1, 7, 30, 90, 
180, and 360 days. Using Beam Walk, Tail Suspension, and Barnes´ Maze tests, we 
evaluated motor function, depression like behavior, and spatial learning and memory. 
Histopathological changes were assessed using immunohistochemistry. CCI led to 
progressive deterioration of motor and memory function and induced increasing 
depressive behavior. Injury volume increased continuously and reached its maximum 
360 days after CCI while the ipsilateral hemisphere became atrophic, including the white 
matter and the hippocampus. A significant enlargement of the ipsilateral lateral ventricle 
was detectable, consistent with hydrocephalus formation. The present study 
demonstrates that after an initial improvement TBI causes progressive chronic 
neuropathological and behavioral deficits up to 12 months after injury. Hence, a second, 
chronic wave of secondary brain damage occurs after TBI, which may be modulated by 
pharmacological treatment or neurorehabilitation.  
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5.2 Zusammenfassung und Ausblick 
Schwere Schädel-Hirn-Traumata (SHT) führen oft zu bleibenden Behinderungen und 
Beeinträchtigungen. Während die Mechanismen der akuten Hirnschädigung nach SHT 
inzwischen relativ gut erforscht sind, gibt es bisher wenige Erkenntnisse zum 
Langzeit-Verlauf des posttraumatischen Hirnschadens, der in Zusammenhang mit sich 
erst im Verlauf der Erkrankung entwickelnden Symptomen wie progredientem 
neurokognitiven Abbau und neuropsychologischen Defiziten gebracht wird. Zur 
Untersuchung dieser chronischen Vorgänge sind experimentelle Modelle notwendig, die 
die humane Pathologie nachbilden. Das Ziel der vorliegenden Studie war die Entwicklung 
eines Maus-Modells zur Untersuchung des chronischen Hirnschadens; als Modell wurde 
das weit verbreitete Controlled Cortical Impact - Modell verwendet, das eine gut 
standardisierbare und quantifizierbare Läsion induziert. Für die Studie wurden 
männliche C57 BL/6 Mäuse einem experimentellem Controlled Cortical Impact SHT 
(8m/s Aufprallgeschwindigkeit, 1 mm Eindringtiefe, 150 ms Kontaktzeit, über dem 
rechten parietalen Kortex) unterzogen und für 15 min, 24 Stunden, 3, 7 Tage oder 1, 2, 6 
oder 12 Monate beobachtet (n=10/Gruppe). Als Kontrollgruppe dienten schein-operierte 
und nicht-traumatisierte (naive) Tiere. Die Tiere wurden regelmäßig mit 
unterschiedlichen Testverfahren untersucht: zur Evaluation motorischer Defizite mit 
dem Beam Walk Test, zur Bestimmung depressiver Symptome mit dem Tail Suspension 
Test sowie zur Quantifizierung der Gedächtnisleistung mit dem Barnes Maze Test. Am 
Ende der jeweiligen Beobachtungsphase wurden die Gehirn entnommen und 
histopathologisch untersucht. Das CCI-Trauma führte zu einer signifikanten und 
progredienten Verschlechterung der motorischen Funktion, der Konzentrations- und 
Gedächtnisleistungen sowie zu zunehmend depressivem Verhalten. Das Läsionsvolumen 
nach bis zum Ende der Beobachtungszeit kontinuierlich zu. Histopathologisch zeigte sich 
eine zunehmende Atrophie der ipsilateralen Hemisphäre, der weißen Substanz (Corpus 
callosum) und beider Hippocampi. Zudem war eine deutliche Erweiterung des 
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ipsilateralen Seitenventrikels nachweisbar, vereinbar mit der Ausbildung eines 
Hydrocephalus. 
Die vorliegende Studie liefert erstmals einen umfassenden Überblick über den zeitlichen 
Verlauf der histologischen und neurokognitiven Veränderungen nach einer einmaligen 
fokalen Hirnläsion. Die Ergebnisse dieser Studie stellen eine wichtige Basis für 
nachfolgende Untersuchungen da und ermöglichen die Untersuchung der Mechanismen, 
die den beobachteten progressiven Langzeitschäden zugrunde liegen.  
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